Skip to main content

Table 1 Characteristics of pre-ART cohorts in Central Kenya between 2004 and 2014

From: Temporal trends in pre-ART patient characteristics and outcomes before the test and treat era in Central Kenya

 

Cohort year

Trend P value

 

2004 (n = 254)

2005 (n = 600)

2006 (n = 1019)

2007 (n = 2266)

2008 (n = 2396)

2009 (n = 1992)

2010 (n = 1531)

2011 (n = 1290)

2012 (n = 1000)

2013 (n = 820)

2014 (n = 612)

Age

           

0.282

0–4 (n = 561)

22 (8.7)

45 (7.5)

73 (7.2)

125 (5.5)

114 (4.8)

59 (3.0)

47 (3.1)

31 (2.4)

21 (2.1)

17 (2.1)

7 (1.1)

 

5–9 (n = 552)

27 (10.7)

51 (8.5)

84 (8.2)

138 (6.1)

79 (3.3)

67 (3.4)

43 (2.8)

24 (1.9)

20 (2.0)

13 (1.6)

6 (1.0)

 

10–14 (n = 242)

7 (2.8)

15 (2.5)

10 (1.0)

38 (1.7)

29 (1.2)

44 (2.2)

35 (2.3)

18 (1.4)

21 (2.1)

8 (1.0)

17 (2.8)

 

15–19 (n = 316)

4 (1.6)

8 (1.3)

12 (1.2)

52 (2.3)

44 (1.8)

34 (1.7)

45 (2.9)

43 (3.3)

26 (2.6)

34 (4.1)

14 (2.3)

 

20–35 (n = 7303)

113 (44.7)

263 (43.8)

491 (48.2)

1191 (52.6)

1315 (54.9)

1093 (54.9)

829 (54.1)

698 (54.1)

563 (56.3)

436 (53.2)

311 (50.8)

 

36–50 (n = 3803)

58 (22.9)

176 (29.3)

278 (27.3)

572 (25.2)

655 (27.3)

562 (28.2)

437 (28.5)

376 (29.1)

262 (26.2)

229 (27.9)

198 (32.4)

 

51 and above (n = 1002)

22 (8.7)

42 (7.0)

71 (7.0)

150 (6.6)

160 (6.7)

133 (6.7)

95 (6.2)

100 (7.8)

87 (8.7)

83 (10.1)

59 (9.6)

 

Sex

           

0.398

Female (n = 9551)

160 (63.2)

407 (67.8)

676 (66.3)

1593 (70.3)

1699 (70.9)

1362 (68.4)

1063 (69.4)

891 (69.1)

705 (70.5)

591 (72.1)

404 (66.0)

 

Male (n = 4228)

93 (36.8)

193 (32.2)

343 (33.7)

673 (29.7)

697 (29.1)

630 (31.6)

468 (30.6)

399 (30.9)

295 (29.5)

229 (27.9)

208 (34.0)

 

Marital status

           

 < 0.001

Divorced (n = 1899)

16 (6.3)

49 (8.2)

86 (8.4)

266 (11.7)

291 (12.1)

274 (13.8)

271 (17.7)

243 (18.8)

142 (14.2)

151 (18.4)

110 (18.0)

 

Married (n = 5881)

54 (21.3)

156 (26.0)

345 (33.9)

935 (41.3)

1075 (44.9)

914 (45.9)

671 (43.8)

601 (46.6)

471 (47.1)

395 (48.2)

264 (43.1)

 

Single (n = 3040)

45 (17.8)

122 (20.3)

188 (18.4)

474 (20.9)

552 (23.0)

457 (22.9)

338 (22.1)

251 (19.5)

237 (23.7)

200 (24.4)

176 (28.8)

 

Widowed (n = 1029)

23 (9.1)

45 (7.5)

100 (9.8)

207 (9.1)

189 (7.9)

130 (6.5)

112 (7.3)

87 (6.7)

63 (6.3)

36 (4.4)

37 (6.0)

 

Not indicated (n = 1930)

115 (45.5)

228 (38.0)

300 (29.4)

384 (16.9)

289 (12.1)

217 (10.9)

139 (9.1)

108 (8.4)

87 (8.7)

38 (4.6)

25 (4.1)

 

WHO stage

           

 < 0.001

Stage I (n = 4732)

22 (8.7)

89 (14.8)

151 (14.8)

585 (25.8)

797 (33.3)

706 (35.4)

630 (41.1)

566 (43.9)

519 (51.9)

403 (49.1)

264 (43.1)

 

Stage II (n = 3251)

44 (17.4)

108 (18.0)

196 (19.2)

561 (24.8)

609 (25.4)

481 (24.1)

351 (22.9)

311 (24.1)

246 (24.6)

193 (23.5)

151 (24.7)

 

Stage III (n = 2113)

72 (28.5)

152 (25.3)

211 (20.7)

414 (18.3)

413 (17.2)

290 (14.6)

171 (11.2)

126 (9.8)

107 (10.7)

91 (11.1)

66 (10.8)

 

Stage IV (n = 268)

10 (4.0)

16 (2.7)

26 (2.6)

38 (1.7)

35 (1.5)

42 (2.1)

39 (2.5)

23 (1.8)

20 (2.0)

12 (1.5)

7 (1.1)

 

Unstaged (n = 3415)

105 (41.5)

235 (39.2)

435 (42.7)

668 (29.5)

542 (22.6)

473 (23.7)

340 (22.2)

264 (20.5)

108 (10.8)

121 (14.8)

124 (20.3)

 

TB status

           

 < 0.001

No signs (n = 10,760)

148 (58.5)

373 (62.2)

670 (65.8)

1578 (69.6)

1810 (75.5)

1601 (80.4)

1299 (84.8)

1123 (87.1)

893 (89.3)

734 (89.5)

531 (86.8)

 

On TB treatment (n = 943)

21 (8.3)

55 (9.2)

88 (8.6)

218 (9.6)

202 (8.4)

146 (7.3)

85 (5.6)

50 (3.9)

28 (2.8)

26 (3.2)

24 (3.9)

 

Presumptive TB (n = 595)

12 (4.7)

6 (1.0)

28 (2.7)

95 (4.2)

130 (5.4)

112 (5.6)

71 (4.6)

50 (3.9)

38 (3.8)

26 (3.2)

27 (4.4)

 

Not indicated (n = 1481)

72 (28.5)

166 (27.7)

233 (22.9)

375 (16.5)

254 (10.6)

133 (6.7)

76 (5.0)

67 (5.2)

41 (4.1)

34 (4.1)

30 (4.9)

 

CD4 category

           

 < 0.001

0–250 (n = 778)

21 (8.3)

25 (4.2)

148 (14.5)

136 (6.0)

109 (4.5)

103 (5.2)

80 (5.2)

48 (3.7)

51 (5.1)

34 (4.1)

23 (3.8)

 

251–500 (n = 136)

0 (0.0)

2 (0.3)

16 (1.6)

22 (1.0)

24 (1.0)

16 (0.8)

8 (0.5)

15 (1.2)

11 (1.1)

10 (1.2)

12 (2.0)

 

Above 500 (n = 43)

2 (0.8)

0 (0.0)

14 (1.4)

9 (0.4)

9 (0.4)

1 (0.1)

5 (0.3)

0 (0.0)

3 (0.3)

0 (0.0)

0 (0.0)

 

No CD4 test (n = 12,822)

230 (90.9)

573 (95.5)

841 (82.5)

2099 (92.6)

2254 (94.1)

1872 (94.0)

1438 (93.9)

1227 (95.1)

935 (93.5)

776 (94.6)

577 (94.3)

Â